A Los Angeles jury has awarded $40 million to two women who claim Johnson & Johnson’s talcum powder caused their ovarian cancer. The company plans to appeal the verdict. This is part of an ongoing legal battle over the alleged link between talc in Johnson’s Baby Powder and cancer. Johnson & Johnson stopped selling talc-based powder globally in 2023. In October, another jury ordered the company to pay $966 million in a similar case. Johnson & Johnson argues that scientific evaluations confirm talc is safe and plans to challenge the verdict.
(Copyright 2025 The Associated Press. All Rights Reserved.)
